# Amneal acquires Kashiv BioSciences creates global biosimilars leader

2026-08-10T23:58:33+00:00 | World & Diplomacy | Indian Opinion Desk

Corroboration: 1 independent outlet

Telangana Today reports that Amneal Pharmaceuticals has completed its acquisition of Kashiv BioSciences, creating a fully integrated global biosimilars leader. The deal combines Kashiv’s biologics R&D and manufacturing with Amneal’s commercial scale. The combined portfolio is expected to support multiple biosimilar launches each year, tapping into more than $300 billion in projected global biologics loss of exclusivity over the next decade. Integration planning is underway. Financial advisers included Goldman Sachs and J.P. Morgan.

## Coverage

- telanganatoday.com <https://telanganatoday.com/amneal-acquires-kashiv-biosciences-creating-global-biosimilars-leader>

Tags: acquisition, Amneal, biosimilars, global, Kashiv BioSciences, pharmaceutical
Canonical: https://indianopinion.org/amneal-acquires-kashiv-biosciences-creates-global-biosimilars-leader/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/amneal-acquires-kashiv-biosciences-creates-global-biosimilars-leader/#story-in-brief

Review state: restored archive article, accurate at time of publication, not offered to search indexes.